Headline News

CHICAGO — For adults at high or very high CVD risk, a monthly PCSK9 inhibitor added to maximally tolerated oral lipid-lowering therapy maintained LDL reductions of more than 60% through 72 weeks, with no signals of attenuation.

A novel, six-step skincare regimen comprised of a “wish list” of ingredients improved the signs of photoaging in men and women, according to a study.

Smith & Nephew reported increased revenue across several businesses in its third quarter of 2024 financial results, according to a company press release.

WASHINGTON — A model predicting the development of systemic lupus erythematosus, based on genetic, lifestyle and environmental factors, was successfully validated in a large cohort, according to data presented at ACR Convergence 2024.

CHICAGO — In the OPTION trial, left atrial appendage closure resulted in similar thromboembolic protection but superior bleeding outcomes compared with oral anticoagulation among patients who underwent ablation for atrial fibrillation.

CHICAGO — Rising outside temperature is associated with increased likelihood for experiencing an episode of atrial fibrillation as detected by implanted cardiac devices, according to new research.

WASHINGTON — Herpes zoster vaccination is effective in patients with systemic lupus erythematosus and multiple sclerosis, without increasing the risk for severe lupus flares, according to data presented at ACR Convergence 2024.

WASHINGTON — Lorecivivint is superior to placebo for improving pain, function and structure at 12 months and beyond in patients with knee osteoarthritis, according to data presented at ACR Convergence 2024.

NEW YORK — The 37th annual Infectious Diseases in Children Symposium will address the possibility that measles and chickenpox may make a comeback due to waning vaccine coverage.

NEW YORK — In this video at the Infectious Diseases in Children Symposium, Catherine Mary Healy, MBBCh, describes what she called “an exciting time” for meningococcal vaccines.